CBD is drawing the attention of not just consumers and law makers, but also firms that want to look into what the compound can do.
Researchers uncover yet another potential health benefit of CBD from cannabis.
The alcoholic beverage market will be worth $1.5 trillion by 2022, while the marijuana industry is projected to arrive at $146.4 billion by 2024.
With its legalization in many states, the cannabis industry is experiencing a boost in medical marijuana, with cannabidiol oil showing the most promise.
A study revealed that apart from its health benefits, the cannabis industry can provide more opportunities for employment and generate more tax revenue.
GW Pharmaceuticals’ Epidiolex is the first FDA-approved cannabis-based drug.
After the Senate's approval, the Canadian government did not accept some of the amendments in the Cannabis Act.
PotNetwork Holdings, Inc. (OTCMKTS:POTN) plans to expand and make its products available to underdeveloped sectors.
A recent study revealed that a significant drop in binge drinking ratings were observed among states which permit the use of recreational cannabis.
The audited FY 2017 results of PotNetwork Holding, Inc. (OTCMKTS:POTN) confirms its stellar performance and huge growth potential this year,